User:CagriCass
Editor·2,499 edits·since 2025/04
CagriCass is an editor on PeptidePedia Wiki, editing since 2025 / 4.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,499Total edits
25Logged here
17Articles touched
2025/04Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Triple agonist | 2 | 30 | 7% |
| Exenatide | 2 | 33 | 6% |
| Retatrutide | 2 | 43 | 5% |
| Amylin | 2 | 37 | 5% |
| International nonproprietary name | 2 | 31 | 6% |
| Fasting insulin | 1 | 31 | 3% |
| Liraglutide | 1 | 37 | 3% |
| Cold chain | 1 | 44 | 2% |
| SUSTAIN trial programme | 1 | 26 | 4% |
| CagriSema | 1 | 31 | 3% |
| Oral semaglutide | 1 | 30 | 3% |
| Lixisenatide | 1 | 26 | 4% |
| TRIUMPH trial programme | 1 | 31 | 3% |
| Timeline of incretin therapeutics | 1 | 30 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.